Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization.
Feng Gao , Xinfang Yu , Ming Li , Li Zhou
Cell Death and Disease 11 ( 2) 143
31
2020
Deguelin attenuates non-small cell lung cancer cell metastasis through inhibiting the CtsZ/FAK signaling pathway.
Wei Li , Xinfang Yu , Xiaolong Ma , Li Xie
Cellular Signalling 50 131 -141
35
2018
The role of necroptosis, an alternative form of cell death, in cancer therapy
Xinfang Yu , Qipan Deng , Ann M Bode , Zigang Dong
Expert Review of Anticancer Therapy 13 ( 7) 883 -893
24
2013
EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
Haidan Liu , Wei Li , Xinfang Yu , Feng Gao
Oncotarget 7 ( 35) 56338 -56354
46
2016
Licochalcone A inhibits EGFR signalling and translationally suppresses survivin expression in human cancer cells.
Feng Gao , Ming Li , Xinfang Yu , Wenbin Liu
Journal of Cellular and Molecular Medicine 25 ( 2) 813 -826
1
2021
Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant
Qipan Deng , Hui Hu , Xinfang Yu , Shuanglin Liu
Nature Communications 10 ( 1) 5061
5
2019
Neoalbaconol induces cell death through necroptosis by regulating RIPK-dependent autocrine TNFα and ROS production
Xinfang Yu , Qipan Deng , Wei Li , Lanbo Xiao
Oncotarget 6 ( 4) 1995 -2008
51
2015
Oxymatrine inhibits non-small cell lung cancer via suppression of EGFR signaling pathway.
Wei Li , Xinfang Yu , Shiming Tan , Wenbin Liu
Cancer Medicine 7 ( 1) 208 -218
22
2018
Neoalbaconol inhibits angiogenesis and tumor growth by suppressing EGFR-mediated VEGF production.
Xinfang Yu , Wei Li , Qipan Deng , Shuo You
Molecular Carcinogenesis 56 ( 5) 1414 -1426
22
2017
Promotion of Ubiquitination-Dependent Survivin Destruction Contributes to Xanthohumol-Mediated Tumor Suppression and Overcomes Radioresistance in Human Oral Squamous Cell Carcinoma
Ming Li , Feng Gao , Xinfang Yu , Qing Zhao
Journal of Experimental & Clinical Cancer Research 39 ( 1) 1 -15
15
2020
Ubiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation
Xinfang Yu , Wei Li , Haidan Liu , Qipan Deng
Journal of Hematology & Oncology 13 ( 1) 40
3
2020
Sinomenine Inhibits Non-Small Cell Lung Cancer via Downregulation of Hexokinases II-Mediated Aerobic Glycolysis.
Wenbin Liu , Xinfang Yu , Li Zhou , Jigang Li
OncoTargets and Therapy 13 3209 -3221
16
2020
Expanding anti-CD38 immunotherapy for lymphoid malignancies
Xu Wang , Xinfang Yu , Wei Li , Praveen Neeli
Journal of Experimental \& Clinical Cancer Research 41 ( 1) 210
4
2022
Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance
Ming Li , Feng Gao , Xiaoying Li , Yu Gan
Cell Death \& Disease 13 ( 12) 1053
2022
PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination
Xinfang Yu , Wei Li , Haidan Liu , Xu Wang
The Journal of Clinical Investigation 133 ( 3)
2023
The role of targeting kinase activity by natural products in cancer chemoprevention and chemotherapy
Xiangjian Luo , Xinfang Yu , Sufang Liu , Qipan Deng
Oncology reports 34 ( 2) 547 -554
40
2015
Skp2 stabilizes Mcl-1 and confers radioresistance in colorectal cancer
Xinfang Yu , Li Zhou , Wenbin Liu , Lijun Liu
Cell Death & Disease 13 ( 3) 249 -249
28
2022
Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells
Huiling Zhou , Li Zhou , Qing Guan , Xuyang Hou
Communications Biology 6 ( 1) 805 -805
3
2023
Correction to: Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance
Ming Li , Feng Gao , Xiaoying Li , Yu Gan
Cell Death & Disease 14 ( 1) 36 -36
1
2023
AI-powered discovery of a novel p53-Y220C reactivator
Shan Zhou , Dafei Chai , Xu Wang , Praveen Neeli
Frontiers in Oncology 13 1229696 -1229696
2
2023